Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center

NCT01465360 · clinicaltrials.gov ↗

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Mild Cognitive Impairment
Vascular Dementia
Fronto-temporal Dementia
Primary Progressive Aphasia
Parkinson' Disease Dementia
Mixed Dementia

Sponsor

Exonhit